Exicure, Inc.
XCUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001698530
No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Exicure, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +4 vs. Q4 2023
- Shares held
- 630.6K
- +43.4K (+7.4%) vs. Q4 2023
- Total value
- $368.4K
- +$26.4K (+7.7%) vs. Q4 2023
- New holders
- 4
- 8 more added
- Sold out
- 0
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XCUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $306.0K |
| Q1 2026 | 19 | $731.4K |
| Q4 2025 | 15 | $803.0K |
| Q3 2025 | 13 | $1.58M |
| Q2 2025 | 15 | $2.62M |
| Q1 2025 | 13 | $4.26M |
| Q4 2024 | 12 | $4.21M |
| Q3 2024 | 12 | $127.3K |
| Q2 2024 | 16 | $171.6K |
| Q1 2024 | 20 | $368.4K |
| Q4 2023 | 16 | $342.0K |
| Q3 2023 | 17 | $470.1K |
| Q2 2023 | 15 | $854.3K |
| Q1 2023 | 15 | $594.1K |
| Q4 2022 | 16 | $898.5K |
| Q3 2022 | 18 | $1.12M |
| Q2 2022 | 18 | $1.56M |
| Q1 2022 | 43 | $5.12M |
| Q4 2021 | 48 | $8.49M |
| Q3 2021 | 47 | $34.9M |
| Q2 2021 | 58 | $44.4M |
| Q1 2021 | 72 | $68.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Exicure, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 281,636 | $160.5K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 65,600 | $39.0K | 0.00% | +16,100+32.5% | Added |
| Geode Capital Management, LLC | 56,519 | $34.0K | 0.00% | +3,523+6.6% | Added |
| Northwestern University | 52,145 | $31.0K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 40,093 | $24.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 34,801 | $20.9K | 0.00% | −23,014−39.8% | Reduced |
| Virtu Financial LLC | 27,043 | $16.0K | 0.00% | +8,369+44.8% | Added |
| Two Sigma Securities, LLC | 22,698 | $13.7K | 0.00% | +5,972+35.7% | Added |
| Citadel Advisors LLC | 18,159 | $10.9K | 0.00% | +18,159 | New |
| Bank of America Corp | 12,800 | $7.69K | 0.00% | +12,800 | New |
| Tower Research Capital LLC (TRC) | 7,032 | $4.23K | 0.00% | +59+0.8% | Added |
| BlackRock Inc. | 5,113 | $3.08K | 0.00% | −12−0.2% | Reduced |
| Morgan Stanley | 3,086 | $1.86K | 0.00% | −185−5.7% | Reduced |
| UBS Group AG | 1,831 | $1.10K | 0.00% | +124+7.3% | Added |
| Advisor Group Holdings, Inc. | 289 | $172 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 61 | $37 | 0.00% | +1+1.7% | Added |
| Farther Finance Advisors, LLC | 45 | $28 | 0.00% | +45 | New |
| JPMorgan Chase & Co | 10 | $6 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 123 | $0 | 0.00% | +30+32.3% | Added |
| Lazard Asset Management LLC | 1,478 | $0 | 0.00% | +1,478 | New |